Comparing levetiracetam with Diazepam in Preventing Febrile Seizure

Phase 3

• Conditions: Simple febrile convulsions.; Simple febrile convulsions; R56.00

• Registration Number: IRCT20230126057236N1
• Lead Sponsor: Yasouj University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 142

Inclusion Criteria

Children between six months and five years who come to the hospital emergency room due to Febrile seizures
well-educated and cooperative parents

Exclusion Criteria

Convulsions caused by meningitis or encephalitis or brain abscess
Seizures lasting more than 15 minutes or repeated seizures
Diazepam or levetiracetam is contraindicated
History of neurodevelopmental disorder or previous neurological disease
Kidney dysfunction

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Seizure recurrences based on parental history. Timepoint: At the beginning of the study (before the start of the intervention) and 8 and 4 weeks after entering the study - drug consumption. Method of measurement: Number of seizure recurrences based on parental history.

Secondary Outcome Measures

Name	Time	Method
Possible drug side effects. Timepoint: Week 8 and 16 after entering the study. Method of measurement: History of parents and clinical examination of the child.